-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KaRskYZM9LVpumbWEm7gDm0PEAYCZwqNAbVlPszN8YczY1Jy2WeOKWJCbXbssnea
 Zb3y2lHoQszACfshwtKufg==

<SEC-DOCUMENT>0000315066-96-000241.txt : 19960213
<SEC-HEADER>0000315066-96-000241.hdr.sgml : 19960213
ACCESSION NUMBER:		0000315066-96-000241
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19960212
SROS:			NONE

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-13379
		FILM NUMBER:		96515672

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FMR CORP
		CENTRAL INDEX KEY:			0000315066
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		IRS NUMBER:				161144965
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		82 DEVONSHIRE ST
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		6175706339

	MAIL ADDRESS:	
		STREET 1:		82 DEVONSHIRE STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<DESCRIPTION>SCHEDULE 13G - 2-14-96 - BIO-RAD LABORATORIES INCORPORATED
<TEXT>
  
 
 
SCHEDULE 13G  
  
Amendment No. 2  
Bio-Rad Laboratories Incorporated  
Class A Common Stock  
Cusip # 090572207  
Filing Fee: No  
 
 
Cusip # 090572207  
Item 1:	Reporting Person - FMR Corp. - (Tax ID:  04-2507163)  
Item 4:	Commonwealth of Massachusetts  
Item 5:	None  
Item 6:	None  
Item 7:	504,400  
Item 8:	None  
Item 9:	504,400  
Item 11:	7.90%  
Item 12:	HC   
  
  
 
 
Cusip # 090572207  
Item 1:	Reporting Person - Edward C. Johnson 3d - (Tax ID:  ###-##-####)  
Item 4:	United States of America  
Item 5:	None  
Item 6:	None  
Item 7:	504,400  
Item 8:	None  
Item 9:	504,400  
Item 11:	7.90%  
Item 12:	IN   
  
 
 
Cusip # 090572207  
Item 1:	Reporting Person - Abigail P. Johnson - (Tax ID:  ###-##-####)  
Item 4:	United States of America  
Item 5:	None  
Item 6:	None  
Item 7:	504,400  
Item 8:	None  
Item 9:	504,400  
Item 11:	7.90%  
Item 12:	IN   
  
 
 
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS  
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)  
  
  
Item 1(a).	Name of Issuer:  
  
		Bio-Rad Laboratories Incorporated  
  
Item 1(b).	Name of Issuer's Principal Executive Offices:  
  
		1000 Alfred Nobel Drive   
		Hercules, CA  94547  
  
Item 2(a).	Name of Person Filing:   
  
		FMR Corp.  
  
Item 2(b).	Address or Principal Business Office or, if None, Residence:  
  
		82 Devonshire Street, Boston, Massachusetts  02109  
  
Item 2(c).	Citizenship:  
  
		Not applicable  
  
Item 2(d).	Title of Class of Securities:  
  
		Class A Common Stock  
  
Item 2(e).	CUSIP Number:    
  
		090572207  
  
Item 3.	This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) and the  
person filing, FMR Corp., is a parent holding company in accordance  
with Section 240.13d-1(b)(ii)(G).  (Note:  See Item 7).  
  
Item 4.	Ownership  
  
	(a)	Amount Beneficially Owned: 
	504,400  
  
	(b)	Percent of Class: 
	7.90%  
  
	(c)	Number of shares as to which such person has:    
  
	(i)	sole power to vote or to direct the vote: 
	None  
  
	(ii)	shared power to vote or to direct the vote: 
	None  
  
	(iii)	sole power to dispose or to direct the disposition of: 
	504,400  
  
	(iv)	shared power to dispose or to direct the disposition of: 
	None  
  
  
 
 
Item 5.	Ownership of Five Percent or Less of a Class.  
  
	Not applicable.  
  
Item 6.	Ownership of More than Five Percent on Behalf of Another Person.  
  
	Various persons have the right to receive or the power to  
direct the receipt of dividends from, or the proceeds from the  
sale of, the Class A common stock of Bio-Rad Laboratories  
Incorporated.  The interest of one person, Fidelity Low-Priced  
Stock Fund, an investment company registered under the  
Investment Company Act of 1940, in the Class A common stock of  
Bio-Rad Laboratories Incorporated, amounted to 436,500 shares  
or 6.84% of the total outstanding Class A common stock at  
December 31, 1995.    
  
Item 7.	Identification and Classification of the Subsidiary Which Acquired  
the Security Being Reported on By the Parent Holding Company.  
  
	See attached Exhibit(s) A and B.  
  
Item 8.	Identification and Classification of Members of the Group.  
  
	Not applicable, see attached Exhibit A.   
  
Item 9.	Notice of Dissolution of Group.  
  
	Not applicable.  
  
Item 10.	Certification.  
  
	By signing below I certify that, to the best of my knowledge  
and belief, the securities referred to above were acquired in  
the ordinary course of business and were not acquired for the  
purpose of and do not have the effect of changing or  
influencing the control of the issuer of such securities and  
were not acquired in connection with or as a participant in any  
transaction having such purpose or effect.  
  
  
Signature  
  
	After reasonable inquiry and to the best of my knowledge and  
belief, I certify that the information set forth in this  
Schedule 13G in connection with FMR Corp.'s beneficial  
ownership of the Class A common stock of Bio-Rad Laboratories  
Incorporated at December 31, 1995 is true, complete and  
correct.   
  
  
  
	February 14, 1996	  
Date  
  
  
  
	/s/Arthur S. Loring  
Signature  
  
  
  
	Arthur S. Loring, Vice  
President	  
Name/Title  
  
 
 
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS  
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)  
  
	Pursuant to the instructions in Item 7 of Schedule 13G, Fidelity  
Management & Research Company ("Fidelity"), 82 Devonshire Street, Boston,  
Massachusetts 02109, a wholly-owned subsidiary of FMR Corp. and an investment  
adviser registered under Section 203 of the Investment Advisers Act of 1940,  
is the beneficial owner of 504,400 shares or 7.90% of the Class A common stock  
outstanding of Bio-Rad Laboratories Incorporated ("the Company") as a result  
of acting as investment adviser to various investment companies registered  
under Section 8 of the Investment Company Act of 1940.    
  
	The ownership of one investment company, Fidelity Low-Priced Stock Fund,  
amounted to 436,500 shares or 6.84% of the Class A common stock outstanding.   
Fidelity Low-Priced Stock Fund has its principal business office at 82  
Devonshire Street, Boston, Massachusetts 02109.    
  
	Edward C. Johnson 3d, FMR Corp., through its control of Fidelity, and the  
Funds each has sole power to dispose of the 504,400 shares owned by the Funds.  
  
	Neither FMR Corp. nor Edward C. Johnson 3d, Chairman of FMR Corp., has  
the sole power to vote or direct the voting of the shares owned directly by  
the Fidelity Funds, which power resides with the Funds' Boards of Trustees.   
Fidelity carries out the voting of the shares under written guidelines  
established by the Funds' Boards of Trustees.  
  
	Members of the Edward C. Johnson 3d family and trusts for their benefit  
are the predominant owners of  Class B shares of common stock of FMR Corp.,  
representing approximately 49% of the voting power of FMR Corp. Mr. Johnson 3d  
owns 12.0% and Abigail P. Johnson owns 24.5% of the aggregate outstanding  
voting stock of FMR Corp.  Mr. Johnson 3d is chairman of FMR Corp. and Abigail  
P. Johnson is a Director of FMR Corp.  The Johnson family group and all other  
Class B  shareholders have entered into a shareholder's voting agreement under  
which all Class B shares will be voted in accordance with the majority vote of  
Class B shares.  Accordingly, through their ownership of voting common stock  
and the execution of the shareholder's voting agreement, members of the  
Johnson family may be deemed, under the Investment Company Act of 1940, to  
form a controlling group with respect to FMR Corp.  
  
 
 
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS  
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)  
  
RULE 13d-1(f)(1)  AGREEMENT  
  
	The undersigned persons, on February 14, 1996, agree and consent to the  
joint filing on their behalf of this Schedule 13G in connection with their  
beneficial ownership of the Class A common stock of Bio-Rad Laboratories  
Incorporated at December 31, 1995.  
  
	FMR Corp.  
	By	/s/Arthur S. Loring  
Arthur S. Loring 
Vice President - Legal  
	Edward C. Johnson 3d  
	By	/s/Arthur S. Loring  
Arthur S. Loring 
Under Power of Attorney dated  
5/17/89 
On File with Schedule 13G for 
Airborne Freight Corp. 9/10/91   
  
	Abigail P. Johnson  
  
  
	By	/s/Arthur S. Loring  
Arthur S. Loring 
Under Power of Attorney dated  
1/5/96 
On File with Schedule 13G for 
Acclaim Entertainment Inc.  
1/10/96  
	Fidelity Management & Research Company  
	By	/s/Arthur S. Loring  
Arthur S. Loring 
Sr. V.P. and General Counsel  
	Fidelity Low-Priced Stock Fund  
	By	/s/Arthur S. Loring  
Arthur S. Loring 
Secretary  
 
</TEXT> 
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
